ADVI Health Experts Attending AVBCC 2025

ADVI Health’s Marc Samuels, JD, MPH, CEO, Lindsay Bealor Greenleaf, JD, MBA, head of policy, research, and analysis, and Alicia Silver, MPP, senior director, emerging therapies, will be attending the Association for Value-Based Cancer Care (AVBCC) Summit from October 22-24, 2025 in New York, NY.

Ahead of the Summit, Alicia Silver will be moderating a panel at the Cell Therapy Commercialization Symposium (CTCS) on Tuesday, October 21, 2025, at 2:05 pm ET at the New York Athletic Club. The panel, Current Strengths and Weaknesses of Medicare and Medicaid Public Payment, will focus on:

• Payment System Reforms, including the current Medicare Prospective Payment System (PPS) and new DRG codes, specifically for T-cell immunotherapies
• Rural Access and Provider Barriers
• Medicaid Payment Innovation

View the full CTCS agenda

During the Summit from October 22-24, our ADVI experts will be participating in numerous panels, including:

Wednesday, October 22, 2025

• 10 am ET: Bull-DOGEd or Kill Bill…What’s at Stake for Cancer Care in 2025 and Beyond | Highlighting the evolving healthcare landscape, given proposed Department of Health and Human Services (HHS) budget cuts, the debate of the 340B drug pricing program, and more, moderated by Alicia Silver
• 4:30 pm ET: Washington’s Healthcare Hangover | The panel will discuss the new health policies that have taken shape since the new administration began nearly eleven months ago, joined by Lindsay Bealor Greenleaf as a panelist

Thursday, October 23, 2025

• 11 am ET: Pharmaceutical and Biotechnology Development Leaders Looking Forward | Highlighting predictions for the future of pharmaceutical and biotechnology innovation, moderated by Marc Samuels

Get in touch to meet with our ADVI experts at AVBCC and learn more about our insights and expertise.